Company profile
Nutriband Inc.
NASDAQ: NTRB · Healthcare · Biotechnology
#793 of 1,418 Healthcare companies by revenue35th-percentile growth
EA Score
52DFH 53DQ 56GM 50SS 34
v0.1 · 65/100 weight · provisional
↑ Altman-Z, balance-sheet leverage · ↓ listing tenure, return on equity
Methodology →Revenue TTM
$1.8M
Rev growth YoY (TTM)
-24.8%
Net income (FY)
-$8.2M
Employees
13
as of 2026-08-20
Market cap
$43.2M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.0M$2.0M2026
Net income-$8.2M-$8.2M2026
Operating income-$8.3M-$8.3M2026
Total assets$7.5M$7.5M2026
Liabilities$868.4k$868.4k2026
Equity$6.7M$6.7M2026
Revenue trend
FY2019 – FY2026 · USD
FY19
FY20
FY22
FY22
FY23
FY24
FY25
FY26
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Nutriband Inc.’s revenue?
Nutriband Inc. booked $2.0M in FY2026 revenue, contracting 4.8% year over year — slower than 65% of Healthcare companies we track, at a -404.1% net margin.
Peers · Healthcare
HealthLynked Corp.34D20/20 Biolabs Inc.29DHumacyte, Inc.27DDianthus Therapeutics, Inc.49DCocrystal Pharma, Inc.31DSagimet Biosciences Inc.36DNeighbors
Orange →Key facts
CEOGareth Sheridan
SectorHealthcare
IndustryBiotechnology
HeadquartersOrlando, FL
ExchangeNASDAQ: NTRB
Employees13
IPO date2021-10-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.